Filing Details
- Accession Number:
- 0001140361-18-042452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-06 09:00:28
- Reporting Period:
- 2018-11-05
- Accepted Time:
- 2018-11-06 09:00:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1092662 | Chembio Diagnostics Inc. | CEMI | Pharmaceutical Preparations (2834) | 880425691 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1756188 | Robert Passas | 3661 Horseblock Road Medford NY 11763 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-05 | 15,000 | $6.75 | 15,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in Chembio Diagnostics, Inc.'s registered public offering of its Common Stock, which was consummated on November 5, 2018.
Billionaire Hedge Funds
